Applied and molecular immunology, cancer immunobiology, vaccines – immunology and technology
My research focuses on T cells as mediators of anti-tumour immunity and inflammation. Specifically, we study the role of inflammation and the unique features of different subsets of T cells and myeloid cells, focussing on cancer and gut-specific immune responses; and how these cell subsets are involved in patient outcome.
We are currently looking at T cell and myeloid cell subsets in colorectal cancer and inflammatory bowel disease to improve diagnosis, prognosis and treatment. We are generating site-specific T cell memory using novel slow release vaccines and analysing the molecular signalling pathways required to maintain these populations.
My current areas of research are mucosal and tumour immune responses and T cell memory.
photo - Kemp Lab past and present
BBiomedSci (Hons) student 2013, PhD student 2014 -
PGDipSci student 2013, PhD student 2014 -
Simon Shirley, MSc student 2015 (with Sarah Hook); PhD student 2016 - (with Julie Cakebread and Ali Hodgkinson, AgResearch)
PhD student 2016 - (with Margaret Currie, University of Otago Christchurch)
MSc student 2015 -
Member, Ako Aotearoa Academy for Tertiary Teaching Excellence
Otago School of Medical Sciences Kaitohutohu
NZ Councillor - Australasian Society for Immunology
University of Otago Supervisor of the Year 2013
T Cell Responses in Colorectal Cancer - Dr Mik Black, Department of Biochemistry, Prof John McCall, Department of Surgery
Immune Scoring in Colorectal Cancer - Prof John McCall, Department of Surgery; Dr Michael Jameson, Waikato DHB
Enhancing T Cell Memory with Vaccination - Prof Sarah Hook, School of Pharmacy
Gut Immune Responses in Patients with Inflammatory Disease - Dr Michael Schultz, Department of Medicine, Dr Grant Butt, Department of Physiology
Genesis Oncology Trust
Cancer Society of New Zealand
Otago School of Medical Sciences
Gastrointestinal Cancer Institute
Roche / NZSO